KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cognex (CGNX) EBITDA (2016 - 2025)

Cognex's EBITDA history spans 17 years, with the latest figure at $35.3 million for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 14.38% year-over-year to $35.3 million, compared with a TTM value of $162.6 million through Dec 2025, up 41.28%, and an annual FY2025 reading of $162.6 million, up 41.28% over the prior year.
  • EBITDA for Q4 2025 was $35.3 million at Cognex, down from $57.8 million in the prior quarter.
  • The five-year high for EBITDA was $92.6 million in Q3 2021, with the low at $12.7 million in Q4 2023.
  • Average EBITDA over 5 years is $48.5 million, with a median of $41.7 million recorded in 2022.
  • Year-over-year, EBITDA soared 1607.34% in 2021 and then plummeted 76.57% in 2023.
  • Tracing CGNX's EBITDA over 5 years: stood at $56.5 million in 2021, then fell by 3.86% to $54.3 million in 2022, then crashed by 76.57% to $12.7 million in 2023, then surged by 142.28% to $30.8 million in 2024, then grew by 14.38% to $35.3 million in 2025.
  • Per Business Quant, the three most recent readings for CGNX's EBITDA are $35.3 million (Q4 2025), $57.8 million (Q3 2025), and $43.4 million (Q2 2025).